Lumida
/ARWR
⌘K
Arrowhead Pharmaceuticals Inc

Arrowhead Pharmaceuticals Inc

ARWR
$82.85USD+0.11%+0.09 today

MARKET CAP

11.7B

P/E (TTM)

FWD P/E

DAY RANGE

$82 – $86

52W RANGE

$28
$95

AI Summary

Stalk
StalkMedium

ARWR has delivered a clear momentum breakout above the ~77 resistance on heavy volume, signaling a new expansionary phase, but price is currently stretched above rising EMAs and in extreme overbought territory. Medium-term bias remains bullish in Stage 2 with HH/HL structure intact. Execution is best deferred until a pullback into the 77–79 support zone near the 9/20 EMAs for better risk–reward.

  • Phase 3 plozasiran cut triglycerides 79–81% and reduced pancreatitis by 78%.
  • Q3 revenue reached $75M vs. $28M YoY; Redempla prescriptions doubled.
  • Q3 net loss widened to $194.3M vs. $175.2M YoY; opex $245M.
Full analysis →

Buying

7

institutions

Selling

11

institutions

New Positions

3

this quarter

Filing Period

Q1 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

SELL14.83 M1.21 B+-3.33 M+6.2%0.02%
JH

Janus Henderson Group Plc

Q1 2026

BUY2.87 M180.24 M+1.59 M+112.0%0.04%
FA

Fisher Asset Management, LLC

Q2 2026

SELL957.69 K78.06 M+-155.88 K+11.8%0.02%
JC

Jpmorgan Chase & Co

Q2 2026

SELL637.40 K51.77 M+-45.67 K+31.5%0.00%
BA

Balyasny Asset Management L.P.

Q2 2026

BUY470.75 K38.37 M+264.34 K+196.5%0.05%
RT

Renaissance Technologies LLC

Q2 2026

SELL468.92 K38.22 M+-567.57 K-41.2%0.05%
MM

Millennium Management LLC

Q2 2026

BUYNEW407.54 K33.22 M+407.54 K+0.0%0.01%
CA

Citadel Advisors LLC

Q2 2026

SELL326.00 K26.57 M+-24.49 K+20.9%0.00%
CP

California Public Employees Retirement System

Q2 2026

SELL256.31 K20.89 M+-819.00+29.6%0.01%
WP

Woodline Partners LP

Q2 2026

SELL200.18 K16.32 M+-200.18 K-35.0%0.05%
AC

Aqr Capital Management LLC

Q2 2026

BUY198.84 K15.82 M+31.63 K+53.2%0.01%
AC

Adar1 Capital Management, LLC

Q2 2026

SELL69.80 K5.69 M+-500.00+29.1%0.26%
BH

Brevan Howard Capital Management LP

Q2 2026

BUYNEW58.92 K4.80 M+58.92 K+0.0%0.04%
PA

Point72 Asset Management, L.P.

Q2 2026

SELL39.90 K3.25 M+-6.50 K+11.8%0.00%
HS

Hussman Strategic Advisors, Inc.

Q2 2026

BUYNEW21.00 K1.71 M+21.00 K+0.0%0.39%
RC

Rockefeller Capital Management L.P.

Q2 2026

BUY5.30 K431.84 K+3.98 K+422.6%0.00%
RI

Rtw Investments, LP

Q2 2026

SELL0.000.00+-585.68 K-100.0%0.00%
BA

Bridgewater Associates, LP

Q2 2026

SELL0.000.00+-95.55 K-100.0%0.00%